Andrei Carvalho Sposito
← Back to Universidade Estadual de Campinas (UNICAMP)
Universidade Estadual de Campinas (UNICAMP)
Andrei Carvalho Sposito works in Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention. Recorded institutional associations include Universidade de São Paulo, Universidade Estadual de Campinas (UNICAMP), Universidade Católica de Brasília.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Diretrizes Brasileiras de Hipertensão Arterial – 2020
2021 · 1,068 citationsElevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
2020 · 904 citationsATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
2017 · 633 citationsEvolution and epidemic spread of SARS-CoV-2 in Brazil
2020 · 572 citationsIV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2007 · 558 citationsV Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 · 454 citationsUpdated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
2019 · 434 citationsA systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
2013 · 352 citationsBeyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review
2014 · 305 citationsElevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
2020 · 176 citationsGLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
2018 · 170 citationsStatin Therapy in Acute Coronary Syndromes
2002 · 159 citationsAnthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
2018 · 153 citationsRole of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor
2020 · 153 citationsCardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
2014 · 143 citationsAdditional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)
1999 · 140 citationsEffect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome
2018 · 131 citationsHypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy
2008 · 122 citationsProprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years
2017 · 121 citationsGuideline For Stable Coronary Artery Disease
2014 · 88 citationsDapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
2021 · 87 citationsEarly Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
2025 · 79 citationsVitamin D for the prevention of cardiovascular disease: Are we ready for that?
2015 · 78 citationsElevated Glucose Levels Favor Sars-Cov-2 Infection and Monocyte Response Through a Hif-1α/Glycolysis Dependent Axis
2020 · 75 citationsSARS-CoV-2 uses CD4 to infect T helper lymphocytes
2023 · 74 citations
